Variant report
Variant | nsv820944 |
---|---|
Chromosome Location | chr5:52458851-52459795 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs74737917 | chr5:52458852-52458853 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs138673077 | chr5:52458947-52458948 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs199805947 | chr5:52458986-52458987 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs559388570 | chr5:52459006-52459007 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs575790384 | chr5:52459029-52459030 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs149241815 | chr5:52459112-52459113 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs201787676 | chr5:52459113-52459114 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs79301198 | chr5:52459115-52459116 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs79164816 | chr5:52459116-52459117 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs35932266 | chr5:52459139-52459140 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs548717394 | chr5:52459142-52459143 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs2591904 | chr5:52459150-52459151 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs531229917 | chr5:52459323-52459324 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs549561397 | chr5:52459357-52459358 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs532800801 | chr5:52459364-52459365 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs184467223 | chr5:52459410-52459411 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs559407386 | chr5:52459413-52459414 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs376073818 | chr5:52459497-52459498 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs558412943 | chr5:52459568-52459569 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs544797836 | chr5:52459580-52459581 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs144459224 | chr5:52459603-52459604 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs536450053 | chr5:52459613-52459614 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs377692912 | chr5:52459638-52459639 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs371275244 | chr5:52459648-52459649 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs554705887 | chr5:52459756-52459757 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Gastric cancer | 22152101 | CNVD |
Oesophago-gastric ulcer | 22152101 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
DNA damage stimulus | 22844521 | CNVD |
DNA repair | 22844521 | CNVD |
Breast cancer | 21785460 | CNVD |
Spinal muscular atrophy | 22422766 | CNVD |
Spinal muscular atrophy | 22558076 | CNVD |
Spinal muscular atrophy | 21320981 | CNVD |
Spinal muscular atrophy | 21762474 | CNVD |
Cancer | 16751803 | CNVD |
Autism | 22495311 | CNVD |
Intellectual disability | 22102821 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21183584 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Melanoma | 18172304 | CNVD |
Glioma | 20126413 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Breast cancer | 22032731 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18694510 | CNVD |
Breast cancer | 17393978 | CNVD |
Cancer | 21359685 | CNVD |
adenomatous polyposis | 22470819 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Cancer | 22429812 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Breast cancer | 21858162 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Leukemia | 17361228 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
5q-syndrome | 17576883 | CNVD |
Gastric cancer | 17908304 | CNVD |
Lung cancer | 16740712 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Lung cancer | 18438408 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Breast cancer | 21364760 | CNVD |
Oral cancer | 21386901 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Bladder cancer | 21909424 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Lung cancer | 21911935 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 19602461 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:52457600-52459000 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
2 | chr5:52458200-52460200 | Weak transcription | NHDF-Ad | bronchial |
3 | chr5:52458200-52461800 | Weak transcription | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
4 | chr5:52458200-52463600 | Weak transcription | IMR90 fetal lung fibroblasts Cell Line | lung |
5 | chr5:52458200-52463600 | Weak transcription | Muscle Satellite Cultured Cells | -- |
6 | chr5:52458200-52463600 | Weak transcription | Osteobl | bone |
7 | chr5:52458400-52460000 | Weak transcription | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
8 | chr5:52458400-52461400 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
9 | chr5:52458600-52460000 | Weak transcription | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
10 | chr5:52458800-52461800 | Weak transcription | Foreskin Melanocyte Primary Cells skin01 | Skin |
11 | chr5:52459000-52460400 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
12 | chr5:52459600-52461200 | Enhancers | Liver | Liver |